APOLO I: controlo da hipocoagulação na fibrilhação auricular

Bonhorst, 2010, Prevalência de fibrilhação auricular na população portuguesa com 40 ou mais anos. Estudo FAMA, Rev Port Cardiol, 29, 331 O’Connell, 1998, Atrial fibrillation and cognitive function: case‐control study, J Neurol Neurosurg Psychiatry., 65, 386, 10.1136/jnnp.65.3.386 Carroll, 2001, Comorbidity associated with atrial fibrillation: a general practice‐based study, Br J Gen Pract., 51 Sudlow, 1998, A community survey of patients with atrial fibrillation: associated disabilities and treatment preferences, Br J Gen Pract., 48, 1775 Sá, 2012, Anticoagulação oral nos muito idosos e seus determinantes clínicos, Rev Port Med Geral Fam., 28, 168 Ascensão, 2006, Fibrilhação auricular e prevenção do tromboembolismo. Estudo numa população de utentes de centros de saúde, Rev Port Clin Geral., 22, 13 Camm, 2012, 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association, Eur Heart J., 33, 2719 Wan, 2008, Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review, Circ Cardiovasc Qual Outcomes., 1, 84, 10.1161/CIRCOUTCOMES.108.796185 Okumura, 2011, Time in the therapeutic range during warfarin therapy in Japanese patients with non‐valvular atrial fibrillation. A multicenter study of its status and infuential factors, Circ J., 75, 2087, 10.1253/circj.CJ-11-0350 Wieloch, 2011, Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo‐embolic complications from the national quality registry AuriculA, Eur Heart J., 32, 2282, 10.1093/eurheartj/ehr134 Van Spall, 2012, Circ J., 126, 2309, 10.1161/CIRCULATIONAHA.112.101808 Melamed, 2011, Quality of anticoagulation control among patients with atrial fibrillation, Am J Manag Care, 17, 232 Rose, 2010, Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA), J Thromb Haemost, 8, 2182, 10.1111/j.1538-7836.2010.03996.x Rose, 2008, Warfarin for atrial fibrillation in community‐based practice, J Thromb Haemost, 6, 1647, 10.1111/j.1538-7836.2008.03075.x Dolan, 2008, Effect of setting, monitoring intensity and patient experience on anticoagulation control: a systematic review and meta‐analysis of the literature, Curr Med Res Opin., 24, 1459, 10.1185/030079908X297349 Ansell, 2007, Quality of clinical documentation and anticoagulation control in patients with chronic nonvalvular atrial fibrillation in routine medical care, Am J Med Qual, 22, 327, 10.1177/1062860607303003 Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med., 361, 1139, 10.1056/NEJMoa0905561 Cruz, 2012, Clínicas de anticoagulação, situação atual e perspetivas futuras, Rev Port Cardiol., 31, 51, 10.1016/S0870-2551(12)70040-9 Ferreira, 2012, Telemonitorização de INR: eficácia e segurança de um sistema de avaliação em 453 doentes, Acta Med Port., 25, 297 Baker, 2009, Meta‐analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States, J Manag Care Pharm, 15, 244, 10.18553/jmcp.2009.15.3.244